Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/23829
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lane, Courtney R | - |
dc.contributor.author | Brett, Judith | - |
dc.contributor.author | Schultz, Mark | - |
dc.contributor.author | Gorrie, Claire L | - |
dc.contributor.author | Stevens, Kerrie | - |
dc.contributor.author | Cameron, Donna R M | - |
dc.contributor.author | St George, Siobhan | - |
dc.contributor.author | van Diemen, Annaliese | - |
dc.contributor.author | Easton, Marion | - |
dc.contributor.author | Stuart, Rhonda L | - |
dc.contributor.author | Sait, Michelle | - |
dc.contributor.author | Peleg, Anton Y | - |
dc.contributor.author | Stewardson, Andrew J | - |
dc.contributor.author | Cheng, Allen C | - |
dc.contributor.author | Spelman, Denis W | - |
dc.contributor.author | Waters, Mary Jo | - |
dc.contributor.author | Ballard, Susan A | - |
dc.contributor.author | Sherry, Norelle L | - |
dc.contributor.author | Williamson, Deborah A | - |
dc.contributor.author | Romanes, Finn | - |
dc.contributor.author | Sutton, Brett | - |
dc.contributor.author | Kwong, Jason C | - |
dc.contributor.author | Seemann, Torsten | - |
dc.contributor.author | Goncalves da Silva, Anders | - |
dc.contributor.author | Stephens, Nicola | - |
dc.contributor.author | Howden, Benjamin P | - |
dc.date | 2020-07-14 | - |
dc.date.accessioned | 2020-07-16T03:31:43Z | - |
dc.date.available | 2020-07-16T03:31:43Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021; 73(11): e3912-e3920 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/23829 | - |
dc.description.abstract | Multi-resistant organisms (MROs) pose a critical threat to public health. Population-based programs for control of MROs such as Carbapenemase-producing Enterobacterales (CPE) have emerged and evaluation is needed. We assess the feasibility and impact of a state-wide CPE surveillance and response program deployed in December 2015 across Victoria, Australia (population 6.5 million). A prospective multi-modal intervention including active screening, carrier isolation, centralised case investigation and comparative pathogen genomics was implemented. We analyze trend in CPE incidence and clinical presentation, risk factors and local transmission over the program's first three years (January 2016 to December 2018). CPE case ascertainment increased over the study period to 1.42 cases/100,000 population, linked to increased screening without a concomitant rise in active clinical infections (0.45-0.60 infections/100,000 population, p=0.640). KPC-2 infection decreased from 0.29 infections/100,000 population prior to intervention to 0.03 infections/100,000 population in 2018 (p=0.003). Comprehensive case investigation identified putative overseas community acquisition. Median time between isolate referral and initial genomic and epidemiological assessment for local transmission was 11 days (IQR 9-14). Prospective surveillance identified numerous small transmission networks (median 2, range 1-19 cases), predominantly IMP and KPC, with median pairwise distance of 8 (IQR 4-13) single nucleotide polymorphisms; low diversity between clusters of the same sequence type suggested genomic cluster definitions alone are insufficient for targeted response. We demonstrate the value of centralised CPE control programs to increase case ascertainment, resolve risk factors and identify putative local transmission through prospective genomic and epidemiological surveillance; methodologies are transferable to low-prevalence settings and MROs globally. | - |
dc.language.iso | eng | - |
dc.subject | Antimicrobial resistance | - |
dc.subject | Carbapenemase producing Enterobacterales | - |
dc.subject | Public Health Surveillance | - |
dc.subject | genomics | - |
dc.subject | infection control | - |
dc.title | Search and Contain: Impact of an integrated genomic and epidemiological surveillance and response program for control of carbapenemase-producing Enterobacterales. | - |
dc.type | Journal Article | - |
dc.identifier.journaltitle | Clinical Infectious Diseases | - |
dc.identifier.affiliation | VICNISS Healthcare Associated Infection Surveillance Coordinating Centre, at the Peter Doherty Institute for Infection & Immunity, Melbourne, Victoria, Australia | en |
dc.identifier.affiliation | Infection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Innovation Walk, Clayton, Victoria, Australia | en |
dc.identifier.affiliation | Monash Infectious Diseases, Monash Health, Monash Medical Centre, Clayton, Victoria, Australia | en |
dc.identifier.affiliation | Department of Health and Human Services, Melbourne, Victoria, Australia | en |
dc.identifier.affiliation | Microbiological Diagnostic Unit Public Health Laboratory, Melbourne, Victoria, Australia | en |
dc.identifier.affiliation | Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection & Immunity , Melbourne, Victoria, Australia | en |
dc.identifier.affiliation | Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia | en |
dc.identifier.affiliation | University of Tasmania, Medical Science Precinct, Hobart, Tasmania, Australia | en |
dc.identifier.affiliation | Department of Microbiology, St Vincent's Hospital Melbourne, Victoria Parade, Fitzroy, Victoria, Australia | en |
dc.identifier.affiliation | Department of Infectious Diseases, Alfred Hospital, and Central Clinical School, Monash University, Melbourne, Victoria, Australia | en |
dc.identifier.affiliation | Department of Microbiology, The Alfred Hospital, Melbourne, Victoria, Australia | en |
dc.identifier.affiliation | School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia | en |
dc.identifier.doi | 10.1093/cid/ciaa972 | - |
dc.identifier.orcid | 0000-0002-7789-8360 | - |
dc.identifier.pubmedid | 32663248 | - |
dc.type.austin | Journal Article | - |
local.name.researcher | Howden, Benjamin P | |
item.grantfulltext | none | - |
item.openairetype | Journal Article | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Infectious Diseases | - |
crisitem.author.dept | Infectious Diseases | - |
crisitem.author.dept | Infectious Diseases | - |
crisitem.author.dept | Microbiology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.